Literature DB >> 10207441

Progressive multifocal leukoencephalopathy and human immunodeficiency virus-associated white matter lesions in AIDS: magnetization transfer MR imaging.

T Ernst1, L Chang, M Witt, I Walot, H Aronow, M Leonido-Yee, E Singer.   

Abstract

PURPOSE: To determine the magnetization transfer features of progressive multifocal leukoencephalopathy (PML) and human immunodeficiency virus (HIV)-associated white matter lesions (WML) (hereafter, HIV-WML) on magnetic resonance (MR) images obtained in patients with acquired immunodeficiency syndrome (AIDS).
MATERIALS AND METHODS: Conventional MR imaging and magnetization transfer MR imaging were performed in 21 AIDS patients with 42 areas of white matter hyperintensity on MR images (13 patients had 25 PML lesions, eight patients had 17 WML). The magnetization transfer ratio was calculated for each lesion.
RESULTS: Compared with normal-appearing white matter (magnetization transfer ratio = 47.9%), both PML and HIV-WML showed reduced magnetization transfer ratio. The magnetization transfer ratio was significantly lower in PML lesions (magnetization transfer ratio = 26.1%) than in HIV-WML (magnetization transfer ratio = 38.0%, P < .0001), and there was no overlap in the magnetization transfer ratio between PML lesions and HIV-WML. The separation in magnetization transfer ratio between the two lesion types was valid for lesion as small as 0.5 cm2.
CONCLUSION: The larger reduction in magnetization transfer ratio for PML lesions is most likely due to demyelination, whereas the reduction in HIV-WML may be associated primarily with gliosis. PML lesions appear to cause strong reductions in magnetization transfer ratio early in the course of disease. Magnetization transfer MR imaging is a noninvasive tool that improves the differentiation between PML and HIV-WML in patients with AIDS.

Entities:  

Mesh:

Year:  1999        PMID: 10207441     DOI: 10.1148/radiology.210.2.r99fe19539

Source DB:  PubMed          Journal:  Radiology        ISSN: 0033-8419            Impact factor:   11.105


  14 in total

1.  Whole brain diffusion tensor imaging in HIV-associated cognitive impairment.

Authors:  Ann B Ragin; Pippa Storey; Bruce A Cohen; Leon G Epstein; Robert R Edelman
Journal:  AJNR Am J Neuroradiol       Date:  2004-02       Impact factor: 3.825

2.  Magnetization transfer ratio in neuro-Behçet disease.

Authors:  Yonca Anik; Zekiye Kural; Ali Demirci; Gür Akansel; Sibel Aksu; Metin Vural
Journal:  Neuroradiology       Date:  2005-01-20       Impact factor: 2.804

Review 3.  Advances in white matter imaging: a review of in vivo magnetic resonance methodologies and their applicability to the study of development and aging.

Authors:  Jeffrey R Wozniak; Kelvin O Lim
Journal:  Neurosci Biobehav Rev       Date:  2006-08-07       Impact factor: 8.989

4.  Pontocerebellar contribution to postural instability and psychomotor slowing in HIV infection without dementia.

Authors:  Edith V Sullivan; Margaret J Rosenbloom; Torsten Rohlfing; Carol A Kemper; Stanley Deresinski; Adolf Pfefferbaum
Journal:  Brain Imaging Behav       Date:  2011-03       Impact factor: 3.978

5.  Automated determination of axonal orientation in the deep white matter of the human brain.

Authors:  Hauke Bartsch; Paul Maechler; Jacopo Annese
Journal:  Brain Connect       Date:  2012

6.  Magnetization transfer changes of grey and white matter in Parkinson's disease.

Authors:  N Tambasco; G P Pelliccioli; P Chiarini; G E Montanari; F Leone; M L Mancini; M Paciaroni; V Gallai
Journal:  Neuroradiology       Date:  2003-02-21       Impact factor: 2.804

Review 7.  MRI in central nervous system infections: A simplified patterned approach.

Authors:  Krithika Rangarajan; Chandan J Das; Atin Kumar; Arun Kumar Gupta
Journal:  World J Radiol       Date:  2014-09-28

8.  Progressive multifocal leukoencephalopathy: diffusion-weighted imaging and pathological correlations.

Authors:  M Bergui; G B Bradac; K K Oguz; A Boghi; C Geda; G Gatti; D Schiffer
Journal:  Neuroradiology       Date:  2003-10-31       Impact factor: 2.804

9.  Topotecan in the treatment of acquired immunodeficiency syndrome-related progressive multifocal leukoencephalopathy.

Authors:  W Royal; B Dupont; D McGuire; L Chang; K Goodkin; T Ernst; M J Post; D Fish; G Pailloux; H Poncelet; M Concha; L Apuzzo; E Singer
Journal:  J Neurovirol       Date:  2003-06       Impact factor: 2.643

10.  Whole brain and localized magnetization transfer measurements are associated with cognitive impairment in patients infected with human immunodeficiency virus.

Authors:  Y Wu; P Storey; A Carrillo; C Saglamer; B A Cohen; L G Epstein; R R Edelman; A B Ragin
Journal:  AJNR Am J Neuroradiol       Date:  2007-10-10       Impact factor: 3.825

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.